✦ LIBER ✦

Systemic treatment after whole-brain radiotherapy may improve survival in RPA class II/III breast cancer patients with brain metastasis

✍ Scribed by Qian Zhang, Jian Chen, XiaoLi Yu, JinLi Ma, Gang Cai…

Book ID: 120753893
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 396 KB
Volume: 114
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-013-1169-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic Treatment after Whole-brain Rad

Systemic Treatment after Whole-brain Radiotherapy may Improve Survival in RPA Class II/III Patients with Brain Metastasis from Breast Cancer

✍ Q. Zhang; J. Chen; G. Cai; Z. Yang; J. Chen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Breast cancer brain metastases: differen

Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)

✍ Niwinska, A.; Murawska, M.; Pogoda, K. 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 111 KB

Breast cancer subtypes and response to s

Breast cancer subtypes and response to systemic treatment after whole-brain radiotherapy in patients with brain metastases

✍ Anna Niwińska; Magdalena Murawska; Katarzyna Pogoda 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

## Abstract ## BACKGROUND: The aim of this study was to assess the role of systemic treatment after whole‐brain radiotherapy (WBRT) in immunohistochemically defined biological subsets of breast cancer patients with brain metastases. ## METHODS: The group of 420 consecutive breast cancer patients

Metronomic oral Vinorelbine and Temozolo

Metronomic oral Vinorelbine and Temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A Phase II study

✍ Liliana Montella; Raffaele Addeo; Gino Leo; Carmine De Rosa; Gregorio Cennamo; R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 37 KB

Metronomic oral vinorelbine and temozolo

Metronomic oral vinorelbine and temozolomide, after whole brain radiotherapy, for the treatment of breast cancer patients with brain metastasis. A phase II study

✍ R. Addeo; L. Montella; G. Leo; C. De Rosa; A. Franco; R. Guarrasi; V. Faiola; G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Both Anti-HER2 Treatment and Chemotherap

Both Anti-HER2 Treatment and Chemotherapy After Whole-Brain Radiation Therapy Improve Survival in Patients With Brain Metastases From HER2-Positive Breast Cancer

✍ Zhang, Q.; Chen, J.; Cai, G.; Yang, Z.; Guo, X.; Chen, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 63 KB